Drug Profile
Tizanidine extended release - Sun Pharma
Alternative Names: SPARC 1401; Tizanidine ERLatest Information Update: 13 Jul 2022
Price :
$50
*
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Antispastics; Benzothiazoles; Imidazolines; Muscle relaxants; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Musculoskeletal pain
Most Recent Events
- 18 Feb 2022 No development reported - Phase-II for Musculoskeletal pain (In volunteers) in Netherlands (PO)
- 13 Oct 2016 Sun Pharma Advanced Research Company completes a phase-II trial in Musculoskeletal pain (In volunteers) in Netherlands (EudraCT2015-003770-32) prior to October 2016
- 20 Sep 2016 Sun Pharma Advanced Research Company plans a phase II trial for Back pain in USA (NCT02887534)